A key committee in the North Carolina House of Representatives has voted to approve legislation that would spend millions to research psilocybin and MDMA.
The House Health Committee voted today to pass House Bill 727, filed by Representative Edward Goodwin. The proposal would establish a $5 million grant program designed specifically to research the medical and therapeutic potential of psilocybin, the psychedelic compound found in magic mushrooms, and MDMA (sometimes referred to as ecstasy).
The program would be overseen by a newly-created Breakthrough Therapies Research Advisory Board. Starting in August of 2024 the Department of Health and Human Services would be required to accept grand applications from research entities and academic institutions that demonstrate a capability of conducting clinical trials on those 21+.
Continue reading